Sonia Rao - Peptides Today News and Research

NX210c: A Preclinical Assessment of a Thrombospondin-Derived Peptide in Spinal Cord Injury

Sonia Rao December 13, 2025 No Comments

NX210c is emerging as one of the more scientifically grounded preclinical candidates in spinal cord injury research. Spinal cord injury, often referred to as SCI, remains a devastating neurological condition…

The Unseen Hand: How Mass Spectrometry Is Steering GLP-1 Therapeutics Toward Unprecedented Market Dominance

Sonia Rao December 11, 2025 No Comments

The global demand for every major GLP-1 therapeutic is rising faster than almost any other treatment class in metabolic medicine. The market is projected to grow from USD 53.46 billion…

PuraStat: Assessing Preclinical Evidence for Enhanced Mucosal Healing Post-Endoscopic Resection

Sonia Rao December 11, 2025 No Comments

The interest in PuraStat mucosal healing has grown quickly as gastroenterologists look for better ways to reduce delayed bleeding and improve recovery after advanced endoscopic procedures. Complex resections like EMR…

Deciphering Sapu Nano’s Deciparticle™ Platform: A Strategic Outlook on Hydrophobic Drug Delivery

Sonia Rao December 10, 2025 No Comments

Hydrophobic Drug Delivery remains one of the most persistent challenges in modern pharmaceutical development. Many promising therapeutic molecules such as macrolides, cyclic peptides, linear peptides, and polyketides demonstrate strong bioactivity,…

Assessing Animate Biosciences’ AI-Designed Peptides: A Clinical Viability Report on Systemic Anti-Inflammatory and Anti-Fibrotic Agents

Sonia Rao December 10, 2025 No Comments

Chronic inflammation and fibrosis affect millions of people worldwide. Researchers estimate that fibrotic diseases contribute to up to 45 percent of global mortality. Because of this, there is growing urgency…

Assessing Biogen’s Strategic Move into Oral Macrocyclic Peptides: A Clinical Viability Report

Sonia Rao November 27, 2025 No Comments

The pharmaceutical landscape for immunological conditions may be on the verge of a major shift. Biogen Inc.’s new collaboration with Dayra Therapeutics marks a strategic move into the growing field…

Revolutionizing Antimicrobial Peptide Discovery: Assessing the Clinical Viability Impact of CG-AMP

Sonia Rao November 27, 2025 No Comments

Antibiotic resistance continues to grow at a pace that outmatches current drug development methods. Researchers estimate that resistant infections may cause up to 10 million deaths per year by 2050…

Assessing Biogen’s Strategic Move into Oral Macrocyclic Peptides with Dayra Therapeutics: A Clinical Viability Report

Sonia Rao November 26, 2025 No Comments

The global market for immunology therapies continues to expand fast. In 2023 it was valued at around 97.58 billion USD, and analysts expect it to grow to about 257 billion…

Author: Sonia Rao

Sign up to Get Latest Updates